Cite
Welén K, Rosendal E, Gisslén M, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2021;doi: 10.1016/j.eururo.2021.12.013.
Welén, K., Rosendal, E., Gisslén, M., Lenman, A., Freyhult, E., Fonseca-Rodríguez, O., Bremell, D., Stranne, J., Balkhed, �. �. �. �., Niward, K., Repo, J., Robinsson, D., Henningsson, A. J., Styrke, J., Angelin, M., Lindquist, E., Allard, A., Becker, M., Rudolfsson, S., Buckland, R., Carlsson, C. T., Bjartell, A., Nilsson, A. C., Ahlm, C., Connolly, A. F., Överby, A. K., & Josefsson, A. (2021). A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. European urology, . https://doi.org/10.1016/j.eururo.2021.12.013
Welén, Karin, et al. "A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data." European urology vol. (2021). doi: https://doi.org/10.1016/j.eururo.2021.12.013
Welén K, Rosendal E, Gisslén M, Lenman A, Freyhult E, Fonseca-Rodríguez O, Bremell D, Stranne J, Balkhed ÅÖ, Niward K, Repo J, Robinsson D, Henningsson AJ, Styrke J, Angelin M, Lindquist E, Allard A, Becker M, Rudolfsson S, Buckland R, Carlsson CT, Bjartell A, Nilsson AC, Ahlm C, Connolly AF, Överby AK, Josefsson A. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2021 Dec 15; doi: 10.1016/j.eururo.2021.12.013. Epub 2021 Dec 15. PMID: 34980495.
Copy
Download .nbib